Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 8, 1999

View Archived Issues

Licensing opportunity from NIH: novel acyltriazene antitumor agents

TxA2 synthase inhibitor may have application in SAH

Bioniche completes merger to create Bioniche Life Sciences

Growth hormone tested in HIV-positive patients with opportunistic infections

Company Profile: Intracel

Selective glucocorticoid receptor modulators codeveloped by Abbott, Ligand

Searle claims wide series of new CETP inhibitors for hyperlipidemic conditions

Novel pyridine and pyrimidine derivatives from Amgen particularly useful for obesity Rx

Antiproliferative agents and protein farnesyltransferase inhibitors designed at RPR

Georgetown U discloses new classes of neuroprotective compounds

Pyrimidine derivatives from Tularik useful for CMV infections

FIP '99: complexes of NO donor with improved physicochemical and pharmacological properties

Sublingual nicotine tablets as alternative to Nicorette gum: clinical results reported at FIP '99

Favorable pharmacokinetics and pharmacodynamics reported for insulin aspart at FIP '99

Valentis and PolyMASC finalize merger

FibroGen and Taisho to collaborate on kidney fibrosis research

Onyx to initiate phase III trial with ONYX-015 in treatment of head and neck cancer

Kirin Brewery reports SAR in the area of Fas/FAP-1 binding inhibitors

D-Pharm's valproic acid derivative completes safety studies

MGI Pharma begins to copromote Azulfidine EN-tabs in RA

Imaging agent NeoTect available in U.S. for lung cancer diagnosis

Novel antibiotics targeting bacterial cell wall biosynthesis synthesized by Incara

Micrologix Biotech receives fast track designation for antimicrobial product

Rhone-Poulenc to proceed with complete divestment of participation in Rhodia

More on Hughes Institute's new anti-HIV compounds with efficacy against resistant strains

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...